Evidence map›Paper›PMID 38327625›Full record

ArticleFrontiers in neurology2024

Comparing the effects of augmented virtual reality treadmill training versus conventional treadmill training in patients with stage II-III Parkinson's disease: the VIRTREAD-PD randomized controlled trial protocol.

Gemma Lombardi, Marco Baccini, Alice Gualerzi, Silvia Pancani, Silvia Campagnini, Stefano Doronzio, Diego Longo, Alessandro Maselli, Giulio Cherubini, Michele Piazzini and 8 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gemma LombardiDepartment of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Marco BacciniIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Alice GualerziIRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.
Silvia PancaniIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Silvia CampagniniIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Stefano DoronzioIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Diego LongoIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Alessandro MaselliIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Giulio CherubiniIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Michele PiazziniIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Tommaso CiapettiIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Cristina PolitoIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Samuele PinnaIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Chiara De SantisDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Marzia BedoniIRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.
Claudio MacchiIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.
Silvia RamatParkinson Unit, Department of NeuroMuscular-Skeletal and Sensorial Organs, AOU Careggi, Florence, Italy.
Francesca CecchiIRCCS Fondazione Don Carlo Gnocchi Onlus, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intensive treadmill training (TT) has been documented to improve gait parameters and functional independence in Parkinson's Disease (PD), but the optimal intervention protocol and the criteria for tailoring the intervention to patients' performances are lacking. TT may be integrated with augmented virtual reality (AVR), however, evidence of the effectiveness of this combined treatment is still limited. Moreover, prognostic biomarkers of rehabilitation, potentially useful to customize the treatment, are currently missing. The primary aim of this study is to compare the effects on gait performances of TT + AVR versus TT alone in II-III stage PD patients with gait disturbance. Secondary aims are to assess the effects on balance, gait parameters and other motor and non-motor symptoms, and patient's satisfaction and adherence to the treatment. As an exploratory aim, the study attempts to identify biomarkers of neuroplasticity detecting changes in Neurofilament Light Chain concentration T0-T1 and to identify prognostic biomarkers associated to blood-derived Extracellular Vesicles. Methods: Single-center, randomized controlled single-blind trial comparing TT + AVR vs. TT in II-III stage PD patients with gait disturbances. Assessment will be performed at baseline (T0), end of training (T1), 3 (T2) and 6 months (T3, phone interview) from T1. The primary outcome is difference in gait performance assessed with the Tinetti Performance-Oriented Mobility Assessment gait scale at T1. Secondary outcomes are differences in gait performance at T2, in balance and spatial-temporal gait parameters at T1 and T2, patients' satisfaction and adherence. Changes in falls, functional mobility, functional autonomy, cognition, mood, and quality of life will be also assessed at different timepoints. The G*Power software was used to estimate a sample size of 20 subjects per group (power 0.95, Conclusion: This study will provide data on the possible superiority of AVR-associated TT over conventional TT in improving gait and other motor and non-motor symptoms in persons with PD and gait disturbances. Results of the exploratory analysis could add information in the field of biomarker research in PD rehabilitation.

Indexed as

balancebiomarkersExtracellular VesiclesfallsgaitParkinson’s diseaserehabilitationtreadmill

Identifiers

PMID38327625
PMCPMC10847255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.